Skip to main content
Top
Published in: European Radiology 10/2012

Open Access 01-10-2012 | Contrast Media

MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation

Authors: C. S. van Kessel, W. B. Veldhuis, M. A. A. J. van den Bosch, M. S. van Leeuwen

Published in: European Radiology | Issue 10/2012

Login to get access

Abstract

Objectives

To assess whether, in patients with normal liver function, a hepatobiliary delay time of 10 min after Gd-EOB-DTPA injection is sufficient for lesion characterisation.

Methods

In 42 consecutive patients with suspected focal liver lesions, dynamic MRI was performed after intravenous Gd-EOB-DTPA, followed by hepatobiliary phases at 5, 10 and 20 min. The following items were assessed at each hepatobiliary phase: parenchymal enhancement, contrast agent excretion in bile ducts, lesion enhancement characteristics (hypo-, iso-, or hyperintensity, rim enhancement, central non-enhancement), and contrast- and signal-to-noise ratios, separately for hypo- and hyperintense lesions.

Results

Following enhancement, parenchymal signal intensity increased significantly up to 10 min (86.3%, P < 0.001), and subsequently stabilised (86.5% after 20 min, P = 0.223). Biliary contrast agent excretion was first observed in 2, 32 and 5 patients after 5, 10 and 20 min respectively. Hepatobiliary lesion enhancement characteristics observed after 5 min persisted during later hepatobiliary phases. CNR and SNR ratios increased significantly (P < 0.05) up to 10 min after enhancement without further increase at 20 min, in hypo- and hyperintense lesions.

Conclusions

If lesion characterisation is the primary reason for performing MRI, a hepatobiliary delay time of 10 min after Gd-EOB-DTPA injection is sufficient in patients with normal liver function.

Key Points

Magnetic resonance imaging is now a first line of investigation of the liver.
Optimal CNR and SNR are achieved 10 min after Gd-EOB-DTPA injection.
Typical enhancement characteristics are observed early and do not change.
Ten-minute hepatobiliary delay is sufficient for characterisation of focal liver lesions.
Literature
1.
go back to reference Schima W, Saini S, Petersein J et al (1999) MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses. J Magn Reson Imaging 10:80–83PubMedCrossRef Schima W, Saini S, Petersein J et al (1999) MR imaging of the liver with Gd-BOPTA: quantitative analysis of T1-weighted images at two different doses. J Magn Reson Imaging 10:80–83PubMedCrossRef
2.
go back to reference Vogl TJ, Pegios W, McMahon C et al (1992) Gadobenate dimeglumine—a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR Am J Roentgenol 158:887–892PubMed Vogl TJ, Pegios W, McMahon C et al (1992) Gadobenate dimeglumine—a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. AJR Am J Roentgenol 158:887–892PubMed
3.
go back to reference Reimer P, Rummeny EJ, Shamsi K et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMed Reimer P, Rummeny EJ, Shamsi K et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMed
4.
go back to reference Reimer P, Vosshenrich R (2010) Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent. Biologics 4:199–212PubMed Reimer P, Vosshenrich R (2010) Detection and characterization of liver lesions using gadoxetic acid as a tissue-specific contrast agent. Biologics 4:199–212PubMed
5.
go back to reference Hammerstingl R, Huppertz A, Breuer J et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467PubMedCrossRef Hammerstingl R, Huppertz A, Breuer J et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467PubMedCrossRef
6.
go back to reference Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275PubMedCrossRef Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275PubMedCrossRef
7.
go back to reference Raman SS, Leary C, Bluemke DA et al (2010) Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr 34:163–172PubMedCrossRef Raman SS, Leary C, Bluemke DA et al (2010) Improved characterization of focal liver lesions with liver-specific gadoxetic acid disodium-enhanced magnetic resonance imaging: a multicenter phase 3 clinical trial. J Comput Assist Tomogr 34:163–172PubMedCrossRef
8.
go back to reference Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L (2009) Consensus report of the 2nd international forum for liver MRI. Eur Radiol 19(Suppl 5):S975–S989PubMedCrossRef Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L (2009) Consensus report of the 2nd international forum for liver MRI. Eur Radiol 19(Suppl 5):S975–S989PubMedCrossRef
9.
go back to reference Lowenthal D, Zeile M, Lim WY et al (2010) Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 21:832–840PubMedCrossRef Lowenthal D, Zeile M, Lim WY et al (2010) Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol 21:832–840PubMedCrossRef
10.
go back to reference Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504–511PubMedCrossRef Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504–511PubMedCrossRef
11.
go back to reference Takao H, Akai H, Tajima T et al (2009) MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 77:325–329PubMedCrossRef Takao H, Akai H, Tajima T et al (2009) MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol 77:325–329PubMedCrossRef
12.
go back to reference Motosugi U, Ichikawa T, Tominaga L et al (2009) Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 19:2623–2629PubMedCrossRef Motosugi U, Ichikawa T, Tominaga L et al (2009) Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 19:2623–2629PubMedCrossRef
13.
go back to reference Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D (2008) Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 18:1577–1586PubMedCrossRef Tschirch FT, Struwe A, Petrowsky H, Kakales I, Marincek B, Weishaupt D (2008) Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma. Eur Radiol 18:1577–1586PubMedCrossRef
14.
go back to reference Kim KA, Kim MJ, Park MS et al (2010) Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid. Radiology 256:475–484PubMedCrossRef Kim KA, Kim MJ, Park MS et al (2010) Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid. Radiology 256:475–484PubMedCrossRef
15.
go back to reference Ringe KI, Gupta RT, Brady CM et al (2010) Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? Radiology 255:451–458PubMedCrossRef Ringe KI, Gupta RT, Brady CM et al (2010) Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? Radiology 255:451–458PubMedCrossRef
16.
go back to reference Kim YK, Kwak HS, Kim CS, Han YM (2009) Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxetic acid. J Magn Reson Imaging 30:437–443PubMedCrossRef Kim YK, Kwak HS, Kim CS, Han YM (2009) Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxetic acid. J Magn Reson Imaging 30:437–443PubMedCrossRef
17.
go back to reference Choi SA, Lee SS, Jung IH, Kim HA, Byun JH, Lee MG (2012) The effect of gadoxetic acid enhancement on lesion detection and characterisation using T2 weighted imaging and diffusion weighted imaging of the liver. Br J Radiol 85:29–36PubMedCrossRef Choi SA, Lee SS, Jung IH, Kim HA, Byun JH, Lee MG (2012) The effect of gadoxetic acid enhancement on lesion detection and characterisation using T2 weighted imaging and diffusion weighted imaging of the liver. Br J Radiol 85:29–36PubMedCrossRef
18.
go back to reference Chiu FY, Jao JC, Chen CY et al (2005) Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 29:176–180PubMedCrossRef Chiu FY, Jao JC, Chen CY et al (2005) Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 29:176–180PubMedCrossRef
19.
go back to reference Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW (2010) Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 20:1052–1060PubMedCrossRef Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW (2010) Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 20:1052–1060PubMedCrossRef
20.
go back to reference Motosugi U, Ichikawa T, Sou H et al (2009) Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). J Magn Reson Imaging 30:849–854PubMedCrossRef Motosugi U, Ichikawa T, Sou H et al (2009) Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). J Magn Reson Imaging 30:849–854PubMedCrossRef
Metadata
Title
MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation
Authors
C. S. van Kessel
W. B. Veldhuis
M. A. A. J. van den Bosch
M. S. van Leeuwen
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
European Radiology / Issue 10/2012
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-012-2486-2

Other articles of this Issue 10/2012

European Radiology 10/2012 Go to the issue